美国LifeSpan Biosciences  
LifeSpan Biosciences公司是分子病理学行业的领头军，销售抗体、免疫组化服务以及蛋白质定位数据库。1995年创立的LifeSpan Biosciences已开发了针对药物标靶主要种类的专有抗体，用以研究这些蛋白质在人正常和患病组织中的表达。
LifeSpan Biosciences在高通量成像和癌症鉴别软件产品中也处于领先地位，正在开发用于在在临诊前期毒理学和癌症诊断方面进行病理学解读的仪器和软件。LifeSpan Biosciences的客户包括位于美国、欧洲和日本的超过100家制药公司。
LifeSpan Biosciences公司目前拥有多达37000种目录抗体，其中近2000种抗体通过了免疫组化验证。LifeSpan Biosciences将继续验证更多的免疫组化抗体。


LifeSpan is the industry leader in molecular pathology. LifeSpan sells antibodies, immunohistochemistry services and localization databases. Founded in 1995, LifeSpan has developed proprietary antibodies to major classes of drug targets to study the expression of these proteins in normal and diseased human tissues.

LifeSpan is also a leader in high-throughput imaging and cancer recognition software and is developing instruments and software for pathology interpretation in preclinical toxicology and cancer diagnostics. LifeSpan's clients include more than 100 pharmaceutical companies in the United States, Europe, and Japan.